Loading...
XNAS
APYX
Market cap150mUSD
Dec 05, Last price  
3.94USD
1D
-2.23%
1Q
101.02%
Jan 2017
9.75%
Name

Apyx Medical Corp

Chart & Performance

D1W1MN
XNAS:APYX chart
P/E
P/S
3.13
EPS
Div Yield, %
Shrs. gr., 5y
0.85%
Rev. gr., 5y
11.31%
Revenues
48m
-8.11%
20,211,14126,676,18228,779,15728,096,51026,953,44724,230,00025,411,00027,671,00023,660,00027,681,00029,520,00036,627,00038,883,00016,686,00028,154,00027,711,00048,517,00044,510,00052,349,00048,102,000
Net income
-23m
L+25.38%
406,2082,683,2062,400,5911,831,788595,522-1,535,000109,000617,000-4,339,000-17,282,000-5,370,000-3,950,000-5,062,00064,009,000-19,650,000-11,906,000-15,200,000-23,278,000-18,713,000-23,463,000
CFO
-18m
L+243.82%
-189,6222,986,2182,041,344742,829-98,332-566,0001,897,000165,000-2,536,000-417,000-5,786,000-2,837,000-3,704,000-21,011,000-18,475,000-16,066,000-10,449,000-20,280,000-5,249,000-18,047,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
IPO date
Jul 22, 1983
Employees
276
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT